These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 30284580)
21. Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort. Vandepapelière J; Aydin S; Cosyns JP; Depresseux G; Jadoul M; Houssiau FA Lupus; 2014 Feb; 23(2):159-65. PubMed ID: 24300780 [TBL] [Abstract][Full Text] [Related]
22. Clinicopathological findings, treatment response and predictors of long-term outcome in a cohort of lupus nephritis patients managed according to the Euro-lupus regime: a retrospective analysis in Sri Lanka. Herath N; Ratnatunga N; Weerakoon K; Wazil A; Nanayakkara N BMC Res Notes; 2017 Feb; 10(1):80. PubMed ID: 28148285 [TBL] [Abstract][Full Text] [Related]
23. Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil. Joo YB; Kang YM; Kim HA; Suh CH; Kim TJ; Park YW; Lee J; Lee JH; Yoo DH; Bae SC; Lee HS; Bang SY Int J Rheum Dis; 2018 May; 21(5):1031-1039. PubMed ID: 29611341 [TBL] [Abstract][Full Text] [Related]
24. Lupus nephritis: a retrospective review of 78 cases from a single center. Martins L; Rocha G; Rodrigues A; Santos J; Vasconcelos C; Correia J; Farinha F; Almeida I; Barbosa P; Guimarães S Clin Nephrol; 2002 Feb; 57(2):114-9. PubMed ID: 11863120 [TBL] [Abstract][Full Text] [Related]
25. Withdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-up. Moroni G; Gallelli B; Quaglini S; Banfi G; Rivolta E; Messa P; Ponticelli C Nephrol Dial Transplant; 2006 Jun; 21(6):1541-8. PubMed ID: 16455674 [TBL] [Abstract][Full Text] [Related]
26. Long-term data on tacrolimus treatment in lupus nephritis. Yap DY; Ma MK; Mok MM; Kwan LP; Chan GC; Chan TM Rheumatology (Oxford); 2014 Dec; 53(12):2232-7. PubMed ID: 24996908 [TBL] [Abstract][Full Text] [Related]
27. Lupus nephritis in childhood: a review of 53 patients followed at a single center. Bogdanović R; Nikolić V; Pasić S; Dimitrijević J; Lipkovska-Marković J; Erić-Marinković J; Ognjanović M; Minić A; Stajić N Pediatr Nephrol; 2004 Jan; 19(1):36-44. PubMed ID: 14634858 [TBL] [Abstract][Full Text] [Related]
28. Relation of peritubular capillary features to class of lupus nephritis. Anutrakulchai S; Titipungul T; Pattay T; Mesung P; Puapairoj A; Sirivongs D; Pongsakul C; Futrakul P; Thinkhamrop B; Johnson RJ BMC Nephrol; 2016 Nov; 17(1):169. PubMed ID: 27829387 [TBL] [Abstract][Full Text] [Related]
29. Chronicity index, especially glomerular sclerosis, is the most powerful predictor of renal response following immunosuppressive treatment in patients with lupus nephritis. Park DJ; Choi SE; Xu H; Kang JH; Lee KE; Lee JS; Choi YD; Lee SS Int J Rheum Dis; 2018 Feb; 21(2):458-467. PubMed ID: 29314776 [TBL] [Abstract][Full Text] [Related]
30. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis. F L; Y T; X P; L W; H W; Z S; H Z; Z H; Lupus; 2008 Jul; 17(7):622-9. PubMed ID: 18625634 [TBL] [Abstract][Full Text] [Related]
31. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up. Mok CC; Ying KY; Yim CW; Siu YP; Tong KH; To CH; Ng WL Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339 [TBL] [Abstract][Full Text] [Related]
32. Effect of complete or partial proteinuria recovery on long-term outcomes of lupus nephritis. Medina-Rosas J; Fung WA; Su J; Touma Z Semin Arthritis Rheum; 2018 Feb; 47(4):557-564. PubMed ID: 28888363 [TBL] [Abstract][Full Text] [Related]
33. Comparative clinical prospective therapeutic study between cyclophosphamide, cyclosporine and azathioprine in the treatment of lupus nephritis. El-Sehemy MS; Al-Saaran AM; Baddour NM; Adam AG; Moez PE Egypt J Immunol; 2006; 13(1):39-52. PubMed ID: 17974149 [TBL] [Abstract][Full Text] [Related]
34. Glomerulomegaly in lupus nephritis: a prognostic marker for renal outcomes. Hanaoka H; Kuwana M; Takeuchi T Int J Rheum Dis; 2015 Sep; 18(7):768-75. PubMed ID: 26179413 [TBL] [Abstract][Full Text] [Related]
35. Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study. Hu WX; Chen YH; Bao H; Liu ZZ; Wang SF; Zhang HT; Liu ZH Lupus; 2015 Sep; 24(10):1067-75. PubMed ID: 25819933 [TBL] [Abstract][Full Text] [Related]
37. Renal outcome in patients with lupus nephritis using a steroid-free regimen of monthly intravenous cyclophosphamide: a prospective observational study. Fischer-Betz R; Chehab G; Sander O; Vordenbäumen S; Voiculescu A; Brinks R; Schneider M J Rheumatol; 2012 Nov; 39(11):2111-7. PubMed ID: 22984276 [TBL] [Abstract][Full Text] [Related]
38. Combination therapy of rituximab and mycophenolate mofetil in childhood lupus nephritis. Hogan J; Godron A; Baudouin V; Kwon T; Harambat J; Deschênes G; Niel O Pediatr Nephrol; 2018 Jan; 33(1):111-116. PubMed ID: 28780657 [TBL] [Abstract][Full Text] [Related]
39. Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years. Srivastava P; Abujam B; Misra R; Lawrence A; Agarwal V; Aggarwal A Lupus; 2016 Apr; 25(5):547-57. PubMed ID: 26637291 [TBL] [Abstract][Full Text] [Related]
40. Lupus nephritis in Egyptian children: a 16-year experience. Elmougy A; Sarhan A; Hammad A; El-Refaey A; Zedan M; Eid R; Laimon W; Elrahman AA; Elhussieni F; El-Sherbeny E; Bakr A J Nephrol; 2015 Oct; 28(5):557-62. PubMed ID: 25491938 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]